Text Size

Temperature Control During Dialysis Treatment

This study has been completed.
Sponsor:
Information provided by:
Regional Hospital Holstebro
ClinicalTrials.gov Identifier:
NCT00438295
First received: February 20, 2007
Last updated: September 14, 2007
Last verified: September 2007
History of Changes
  Purpose

The purpose is to measure the effect of glucose in the dialysis water on blood pressure, pulse rate, and plasma glucose with and without body temperature control


Condition Intervention Phase
Renal Failure, Chronic
 Procedure: temperature control
 Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Pharmacodynamics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effect of Temperature Control During Dialysis Treatment With Glucose in Dialysis Water in Patients With Chronic Renal Failure

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Regional Hospital Holstebro:

Primary Outcome Measures:
  • Effect of temperature control on blood pressure, pulse rate and blod glucose during dialysis treatment

Enrollment: 18
Study Start Date: August 2006
Study Completion Date: May 2007
Detailed Description:

To clarify the influence of temperature in dialysis water on blood pressure and vasoactive hormones

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Age > 18 years,
  2. both men and women,
  3. chronic renal failure and dialysis treatment for at least three months

Exclusion Criteria:

  1. Heart failure,
  2. Lung insufficiency,
  3. Chronic liver disease,
  4. Diabetes mellitus,
  5. Malignant disease,
  6. Nephrotic syndrome,
  7. Lack of compliance,
  8. Unwillingness til participate
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00438295

Locations
Denmark
Holstebro Hospital
Holstebro, Denmark, 7500
Sponsors and Collaborators
Regional Hospital Holstebro
Investigators
Study Chair: Erling B Pedersen, Professor Regional Hospital Holstebro
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00438295     History of Changes
Other Study ID Numbers: MED.RES.2007.03.EBP
Study First Received: February 20, 2007
Last Updated: September 14, 2007
Health Authority: Denmark: Ethics Committee

Keywords provided by Regional Hospital Holstebro:
glucose in dialysis water, dialysis treatment, temperature

Additional relevant MeSH terms:
Kidney Failure, Chronic
Renal Insufficiency
Renal Insufficiency, Chronic
Kidney Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on May 19, 2013